METAP2 Antikörper (N-Term)
Kurzübersicht für METAP2 Antikörper (N-Term) (ABIN631470)
Target
Alle METAP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- METAP2 antibody was raised against the N terminal of METAP2
-
Aufreinigung
- Affinity purified
-
Immunogen
- METAP2 antibody was raised using the N terminal of METAP2 corresponding to a region with amino acids ATGKKKKKKKKKRGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGR
-
-
-
-
Applikationshinweise
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
METAP2 Blocking Peptide, (ABIN936942), is also available for use as a blocking control in assays to test for specificity of this METAP2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of METAP2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- METAP2 (Methionyl Aminopeptidase 2 (METAP2))
-
Andere Bezeichnung
- METAP2
-
Hintergrund
- METAP2 is a member of the methionyl aminopeptidase family and encodes a protein that binds 2 cobalt or manganese ions. This protein functions both by protecting the alpha subunit of eukaryotic initiation factor 2 from inhibitory phosphorylation and by removing the amino-terminal methionine residue from nascent protein. Increased expression of this gene is associated with various forms of cancer and the anti-cancer drugs fumagillin and ovalicin inhibit the protein by irreversibly binding to its active site.
-
Molekulargewicht
- 53 kDa (MW of target protein)
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-